Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelarabine and Methotrexate in Newly Diagnosed T-ALL and T-LLy
NCT00408005Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2007
- Primary completion
- Sep 2017
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of nelarabine, methotrexate in t-cell acute lymphoblastic leukemia (T-ALL), T cell lymphoblastic lymphoma (T-LBL), sponsored by National Cancer Institute. Started Jan 2007; status: completed.
02
Drugs
nelarabinemethotrexate
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)T cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT00408005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408005.